Center-Authored Papers

Filters: Author is Torok-Storb, B  [Clear All Filters]
1994
Schuening F, Miller AD, Torok-Storb B, Bensinger W, Storb R, Reynolds T, Fisher L, Buckner CD, Appelbaum FR.  1994.  Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation.. Human gene therapy. 5(12):1523-34.
1996
Mielcarek M, Roecklein BA, Torok-Storb B.  1996.  CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma.. Blood. 87(2):574-80. Abstract
1997
Mielcarek M, Reems J, Torok-Storb B.  1997.  Extrinsic control of stem cell fate: practical considerations.. Stem cells (Dayton, Ohio). 15 Suppl 1:229-32;discussion233-6. Abstract
Reems JA, Mielcarek M, Torok-Storb B.  1997.  Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(3):133-41. Abstract
Mielcarek M, Martin PJ, Torok-Storb B.  1997.  Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.. Blood. 89(5):1629-34. Abstract
Mielcarek M, Torok-Storb B.  1997.  Phenotype and engraftment potential of cytokine-mobilized peripheral blood mononuclear cells.. Current opinion in hematology. 4(3):176-82. Abstract
1998
Tanaka J, Mielcarek M, Torok-Storb B.  1998.  Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells.. Blood. 91(1):347-52. Abstract
Mielcarek M, Graf L, Johnson G, Torok-Storb B.  1998.  Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation.. Blood. 92(1):215-22. Abstract
1999
Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R.  1999.  Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation.. British journal of haematology. 105(2):361-5. Abstract
2000
Mielcarek M, Leisenring W, Torok-Storb B, Storb R.  2000.  Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.. Blood. 96(3):1150-6. Abstract
2002
Awaya N, Baerlocher GM, Manley TJ, Sanders JE, Mielcarek M, Torok-Storb B, Lansdorp PM.  2002.  Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 8(11):597-600. Abstract
Randolph-Habecker J, Iwata M, Torok-Storb B.  2002.  Cytomegalovirus mediated myelosuppression.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 25 Suppl 2:S51-6. Abstract
Maciej Zaucha J, Mielcarek M, Takatu A, Little M-T, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T et al..  2002.  Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.. British journal of haematology. 119(3):740-50. Abstract
Randolph-Habecker J, Iwata M, Geballe AP, Jarrahian S, Torok-Storb B.  2002.  Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production.. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 22(7):765-72. Abstract
Randolph-Habecker J, Rahill B, Torok-Storb B, Vieira J, Kolattukudy PE, Rovin BH, Sedmak DD.  2002.  The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production.. Cytokine. 19(1):37-46. Abstract
Mielcarek M, Sandmaier BM, Maloney DG, Maris M, McSweeney PA, Woolfrey A, Chauncey T, Feinstein L, Niederwieser D, Blume KG et al..  2002.  Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.. Journal of clinical immunology. 22(2):70-4. Abstract
Mielcarek M, Torok-Storb B, Storb R.  2002.  ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.. Bone marrow transplantation. 30(8):547-8;authorreply548.
2004
Kahl C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B.  2004.  Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(12):826-33. Abstract
Mielcarek M, Martin PJ, Heimfeld S, Storb R, Torok-Storb B.  2004.  CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.. Leukemia & lymphoma. 45(1):27-34. Abstract
2005
Mielcarek M, Gooley T, Martin PJ, Chauncey TR, Young BA, Storb R, Torok-Storb B.  2005.  Effects of race on survival after stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(3):231-9. Abstract
2007
Mielcarek M, Kucera KA, Nash R, Torok-Storb B, McKenna HJ.  2007.  Identification and characterization of canine dendritic cells generated in vivo.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(11):1286-93. Abstract
2008
Pillai MM, Venkataraman GM, Kosak S, Torok-Storb B.  2008.  Integration site analysis in transgenic mice by thermal asymmetric interlaced (TAIL)-PCR: segregating multiple-integrant founder lines and determining zygosity.. Transgenic research. 17(4):749-54. Abstract
Hayes B, Fagerlie SR, Ramakrishnan A, Baran S, Harkey M, Graf L, Bar M, Bendoraite A, Tewari M, Torok-Storb B.  2008.  Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.. Stem cells (Dayton, Ohio). 26(2):465-73. Abstract
2009
Pillai MM, Hayes B, Torok-Storb B.  2009.  Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 - and CSF-1R-expressing populations.. Experimental hematology. 37(12):1387-92. Abstract
2010
Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B.  2010.  MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells.. PloS one. 5(12):e14304. Abstract